Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
89Zr-immuno-PET using the anti-LAG-3 tracer [89Zr]Zr-BI 754111: demonstrating target specific binding in NSCLC and HNSCC.
Miedema IHC, Huisman MC, Zwezerijnen GJC, Grempler R, Pitarch AP, Thiele A, Hesse R, Elgadi M, Peltzer A, Vugts DJ, van Dongen GAMS, de Gruijl TD, Menke-van der Houven van Oordt CW, Bahce I. Miedema IHC, et al. Among authors: zwezerijnen gjc. Eur J Nucl Med Mol Imaging. 2023 Jun;50(7):2068-2080. doi: 10.1007/s00259-023-06164-w. Epub 2023 Mar 2. Eur J Nucl Med Mol Imaging. 2023. PMID: 36859619 Free PMC article.
Biochemically Silent Sympathetic Paraganglioma, Pheochromocytoma, or Metastatic Disease in SDHD Mutation Carriers.
Dreijerink KMA, Rijken JA, Compaijen CJ, Timmers HJLM, van der Horst-Schrivers ANA, van Leeuwaarde RS, van Dam PS, Leemans CR, van Dam EWCM, Dickhoff C, Dommering CJ, de Graaf P, Zwezerijnen GJC, van der Valk P, Menke-Van der Houven van Oordt CW, Hensen EF, Corssmit EPM, Eekhoff EMW. Dreijerink KMA, et al. Among authors: zwezerijnen gjc. J Clin Endocrinol Metab. 2019 Nov 1;104(11):5421-5426. doi: 10.1210/jc.2019-00202. J Clin Endocrinol Metab. 2019. PMID: 31194241
Pelvic lymph-node staging with 18F-DCFPyL PET/CT prior to extended pelvic lymph-node dissection in primary prostate cancer - the SALT trial.
Jansen BHE, Bodar YJL, Zwezerijnen GJC, Meijer D, van der Voorn JP, Nieuwenhuijzen JA, Wondergem M, Roeleveld TA, Boellaard R, Hoekstra OS, van Moorselaar RJA, Oprea-Lager DE, Vis AN. Jansen BHE, et al. Among authors: zwezerijnen gjc. Eur J Nucl Med Mol Imaging. 2021 Feb;48(2):509-520. doi: 10.1007/s00259-020-04974-w. Epub 2020 Aug 12. Eur J Nucl Med Mol Imaging. 2021. PMID: 32789599 Free PMC article. Clinical Trial.
18F-FDG PET baseline radiomics features improve the prediction of treatment outcome in diffuse large B-cell lymphoma.
Eertink JJ, van de Brug T, Wiegers SE, Zwezerijnen GJC, Pfaehler EAG, Lugtenburg PJ, van der Holt B, de Vet HCW, Hoekstra OS, Boellaard R, Zijlstra JM. Eertink JJ, et al. Among authors: zwezerijnen gjc. Eur J Nucl Med Mol Imaging. 2022 Feb;49(3):932-942. doi: 10.1007/s00259-021-05480-3. Epub 2021 Aug 18. Eur J Nucl Med Mol Imaging. 2022. PMID: 34405277 Free PMC article.
Aberrant patterns of PET response during treatment for DLBCL patients with MYC gene rearrangements.
Eertink JJ, Arens AIJ, Huijbregts JE, Celik F, de Keizer B, Stroobants S, de Jong D, Wiegers SE, Zwezerijnen GJC, Burggraaff CN, Boellaard R, de Vet HCW, Hoekstra OS, Lugtenburg PJ, Chamuleau MED, Zijlstra JM; HOVON imaging workgroup. Eertink JJ, et al. Among authors: zwezerijnen gjc. Eur J Nucl Med Mol Imaging. 2022 Feb;49(3):943-952. doi: 10.1007/s00259-021-05498-7. Epub 2021 Sep 2. Eur J Nucl Med Mol Imaging. 2022. PMID: 34476551 Free PMC article.
Praluzatamab Ravtansine, a CD166-Targeting Antibody-Drug Conjugate, in Patients with Advanced Solid Tumors: An Open-Label Phase I/II Trial.
Boni V, Fidler MJ, Arkenau HT, Spira A, Meric-Bernstam F, Uboha N, Sanborn RE, Sweis RF, LoRusso P, Nagasaka M, Garcia-Corbacho J, Jalal S, Harding JJ, Kim SK, Miedema IHC, Vugts DJ, Huisman MC, Zwezerijnen GJC, van Dongen GAMS, Menke van der Houven van Oordt CW, Wang S, Dang T, Zein IA, Vasiljeva O, Lyman SK, Paton V, Hannah A, Liu JF. Boni V, et al. Among authors: zwezerijnen gjc. Clin Cancer Res. 2022 May 13;28(10):2020-2029. doi: 10.1158/1078-0432.CCR-21-3656. Clin Cancer Res. 2022. PMID: 35165101 Free PMC article. Clinical Trial.
3D Convolutional Neural Network-Based Denoising of Low-Count Whole-Body 18F-Fluorodeoxyglucose and 89Zr-Rituximab PET Scans.
de Vries BM, Golla SSV, Zwezerijnen GJC, Hoekstra OS, Jauw YWS, Huisman MC, van Dongen GAMS, Menke-van der Houven van Oordt WC, Zijlstra-Baalbergen JJM, Mesotten L, Boellaard R, Yaqub M. de Vries BM, et al. Among authors: zwezerijnen gjc. Diagnostics (Basel). 2022 Feb 25;12(3):596. doi: 10.3390/diagnostics12030596. Diagnostics (Basel). 2022. PMID: 35328149 Free PMC article.
PET-CT Imaging of Polymeric Nanoparticle Tumor Accumulation in Patients.
Miedema IHC, Zwezerijnen GJC, Huisman MC, Doeleman E, Mathijssen RHJ, Lammers T, Hu Q, van Dongen GAMS, Rijcken CJF, Vugts DJ, Menke-van der Houven van Oordt CW. Miedema IHC, et al. Among authors: zwezerijnen gjc. Adv Mater. 2022 May;34(21):e2201043. doi: 10.1002/adma.202201043. Epub 2022 Apr 25. Adv Mater. 2022. PMID: 35427430
Comparing lesion and feature selections to predict progression in newly diagnosed DLBCL patients with FDG PET/CT radiomics features.
Eertink JJ, Zwezerijnen GJC, Cysouw MCF, Wiegers SE, Pfaehler EAG, Lugtenburg PJ, van der Holt B, Hoekstra OS, de Vet HCW, Zijlstra JM, Boellaard R. Eertink JJ, et al. Among authors: zwezerijnen gjc. Eur J Nucl Med Mol Imaging. 2022 Nov;49(13):4642-4651. doi: 10.1007/s00259-022-05916-4. Epub 2022 Aug 4. Eur J Nucl Med Mol Imaging. 2022. PMID: 35925442 Free PMC article.
52 results